Urolution
Urolution™ was co-founded in 2021 by Weihao Qu to bring innovative medical devices to U.S. and international markets.
One of the first products Urolution™ is introducing is the OpenFlo™ urinary catheter, designed as a safe, effective, and patient-centered improvement to the traditional Foley catheter. Since its inception, Urolution™ has been involved in the design, manufacturing, and marketing of the OpenFlo™ catheter for FDA clinical trials and, ultimately, for worldwide sale and distribution.
As part of its broader product innovation process, Urolution™ designs, manufactures, and markets breakthrough healthcare technologies. The company’s expertise spans product development, regulatory preparation, clinical trial support, and global market entry, supporting both its own innovations and those of partners committed to advancing access to high-quality medical devices.
One of the first products Urolution™ is introducing is the OpenFlo™ urinary catheter, designed as a safe, effective, and patient-centered improvement to the traditional Foley catheter. Since its inception, Urolution™ has been involved in the design, manufacturing, and marketing of the OpenFlo™ catheter for FDA clinical trials and, ultimately, for worldwide sale and distribution.
As part of its broader product innovation process, Urolution™ designs, manufactures, and markets breakthrough healthcare technologies. The company’s expertise spans product development, regulatory preparation, clinical trial support, and global market entry, supporting both its own innovations and those of partners committed to advancing access to high-quality medical devices.
©2026 Urolution Medical Inc.